AIM: To assess the performance of the Finnish Diabetes Risk Score (FINDRISC) questionnaire for detecting and predicting type 2 diabetes mellitus (DM2) in a Colombian population. METHODS: This is a longitudinal observational study conducted in Floridablanca, Colombia. Adult subjects (age ≥ 35 years) without known diabetes, were included. A modified version of FINDRISC was completed, and the glycemia values from all the subjects were collected from the hospital's database. Firstly, a cross-sectional analysis was performed and then, the subsample of prediabetic participants was followed for diabetes incidence. RESULTS: A total of 772 subjects were suitable for the study. The overall prevalence of undiagnosed DM2 was 2.59%, and the incidence of DM2 among the prediabetic participants was 7.5 per 100 person-years after a total of 265257 person-years follow-up. The FINDRISC at baseline was significantly associated with undiagnosed and incident DM2. The area under receiver operating characteristics curve of the FINDRISC score for detecting undiagnosed DM2 in both men and women was 0.7477 and 0.7175, respectively; and for predicting the incidence of DM2 among prediabetics was 71.99% in men and 67.74% in women. CONCLUSION: The FINDRISC questionnaire is a useful screening tool to identify cross-sectionally unknown DM2 and to predict the incidence of DM2 among prediabetics in the Colombian population.
AIM: To assess the performance of the Finnish Diabetes Risk Score (FINDRISC) questionnaire for detecting and predicting type 2 diabetes mellitus (DM2) in a Colombian population. METHODS: This is a longitudinal observational study conducted in Floridablanca, Colombia. Adult subjects (age ≥ 35 years) without known diabetes, were included. A modified version of FINDRISC was completed, and the glycemia values from all the subjects were collected from the hospital's database. Firstly, a cross-sectional analysis was performed and then, the subsample of prediabetic participants was followed for diabetes incidence. RESULTS: A total of 772 subjects were suitable for the study. The overall prevalence of undiagnosed DM2 was 2.59%, and the incidence of DM2 among the prediabetic participants was 7.5 per 100 person-years after a total of 265257 person-years follow-up. The FINDRISC at baseline was significantly associated with undiagnosed and incident DM2. The area under receiver operating characteristics curve of the FINDRISC score for detecting undiagnosed DM2 in both men and women was 0.7477 and 0.7175, respectively; and for predicting the incidence of DM2 among prediabetics was 71.99% in men and 67.74% in women. CONCLUSION: The FINDRISC questionnaire is a useful screening tool to identify cross-sectionally unknown DM2 and to predict the incidence of DM2 among prediabetics in the Colombian population.
Authors: Elizabeth Selvin; Michael W Steffes; Hong Zhu; Kunihiro Matsushita; Lynne Wagenknecht; James Pankow; Josef Coresh; Frederick L Brancati Journal: N Engl J Med Date: 2010-03-04 Impact factor: 91.245
Authors: Monica Franciosi; Giorgia De Berardis; Maria C E Rossi; Michele Sacco; Maurizio Belfiglio; Fabio Pellegrini; Gianni Tognoni; Miriam Valentini; Antonio Nicolucci Journal: Diabetes Care Date: 2005-05 Impact factor: 19.112
Authors: Jose Lopez-Lopez; Jennifer Garay; Edwin Wandurraga; Paul A Camacho; Fernando Higuera-Escalante; Daniel Cohen; Patricio Lopez-Jaramillo Journal: PLoS One Date: 2018-04-13 Impact factor: 3.240
Authors: Patricio López-Jaramillo; Ramfis E Nieto-Martínez; Gestne Aure-Fariñez; Carlos O Mendivil; Rodolfo A Lahsen; Ruy L Silva-Filho; Luiz A Andreotti; Mónica E Manrique; Miguel A Pasquel-Andrade; Ignacio Rangel; Maricela Vidrio; Rutila Castañeda; Manuela Restrepo; Miguel E Pinto Journal: Rev Panam Salud Publica Date: 2017-12-12
Authors: Anne Jølle; Kristian Midthjell; Jostein Holmen; Sven Magnus Carlsen; Jaakko Tuomilehto; Johan Håkon Bjørngaard; Bjørn Olav Åsvold Journal: BMJ Open Diabetes Res Care Date: 2019-11-28